NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

A new technology for measuring genotypic resistance to nucleoside analogs. Application to the study of naive patients.

Livrozet JM, Jeanblanc F, Brunel F, Makhloufi D, Saint-Marc T, Touraine JL, Aymard M, Tardy JC; Conference on Retroviruses and Opportunistic Infections.

Program Abstr 5th Conf Retrovir Oppor Infect Conf Retrovir Oppor Infect 5th 1998 Chic Ill. 1998 Feb 1-5; 5th: 142 (abstract no. 336).

Hopital Edouard Herriot, Lyon, France.

Objective: To determine the prevalence of T215 Y/F, L74V, T69D, and M184 V mutations among naive patients. Studied population and methods: A nested PCR - based differential probe hybridation was used for the determination of mutant and wild-type species in plasma virus RNA. It was applied to the study of 70 asymptomatic, naive patients. The mean HIV RNA (Amplicor Monitor Roche) was 4.4 log 10. Results: The sensitivity of the assay enabled us to detect 250 copies/ml. In a mixed population containing both resistant and sensitive species, this technique can identify a minor resistant population with a threshold of 10 %. Applied to the study of naive patients, the assays showed the presence of the mutation 215 in only one patient (1.4%). The other mutations (74, 69, 184) were never found. Conclusion: Among naive patients, mutations confirming resistance to NRTIs are rare in plasma virus RNA. The determination of genotype susceptibility does not seem necessary at the present time, before the initiation of the first treatment, although it is important to be carried out in patients who have already been treated with NRTIs.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Biomedical Research
  • Genotype
  • HIV Infections
  • Humans
  • Prevalence
  • RNA, Viral
  • genetics
Other ID:
  • 98929263
UI: 102235916

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov